Christopher Koh

6.9k total citations
138 papers, 3.3k citations indexed

About

Christopher Koh is a scholar working on Epidemiology, Hepatology and Surgery. According to data from OpenAlex, Christopher Koh has authored 138 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 80 papers in Epidemiology, 77 papers in Hepatology and 28 papers in Surgery. Recurrent topics in Christopher Koh's work include Liver Disease Diagnosis and Treatment (59 papers), Hepatitis C virus research (53 papers) and Hepatitis B Virus Studies (47 papers). Christopher Koh is often cited by papers focused on Liver Disease Diagnosis and Treatment (59 papers), Hepatitis C virus research (53 papers) and Hepatitis B Virus Studies (47 papers). Christopher Koh collaborates with scholars based in United States, Türkiye and Canada. Christopher Koh's co-authors include Theo Heller, David E. Kleiner, Yaron Rotman, T. Jake Liang, Jay H. Hoofnagle, Joseph M. Zmuda, Jake T. Liang, Jeffrey S. Glenn, Pallavi Surana and Ben L. Da and has published in prestigious journals such as SHILAP Revista de lepidopterología, Gastroenterology and Hepatology.

In The Last Decade

Christopher Koh

129 papers receiving 3.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Christopher Koh United States 31 2.2k 1.8k 478 367 326 138 3.3k
Hiroshi Yatsuhashi Japan 38 2.9k 1.3× 3.0k 1.6× 441 0.9× 500 1.4× 506 1.6× 185 4.4k
Zu‐Yau Lin Taiwan 37 2.8k 1.3× 3.0k 1.6× 234 0.5× 351 1.0× 538 1.7× 205 4.3k
Georgios Germanidis Greece 27 2.4k 1.1× 2.5k 1.3× 563 1.2× 170 0.5× 480 1.5× 90 3.9k
Akihiro Matsumoto Japan 37 3.3k 1.5× 3.1k 1.7× 223 0.5× 576 1.6× 370 1.1× 132 4.4k
Norihiro Furusyo Japan 34 1.9k 0.9× 1.8k 1.0× 355 0.7× 395 1.1× 267 0.8× 200 3.5k
Athanasios J. Archimandritis Greece 36 1.9k 0.9× 1.3k 0.7× 301 0.6× 884 2.4× 247 0.8× 134 3.3k
Takeji Umemura Japan 36 3.0k 1.4× 2.5k 1.3× 467 1.0× 1.2k 3.3× 483 1.5× 223 4.8k
Norio Horiike Japan 35 2.2k 1.0× 2.2k 1.2× 896 1.9× 326 0.9× 269 0.8× 166 3.8k
Jee‐Fu Huang Taiwan 38 4.0k 1.8× 3.9k 2.1× 211 0.4× 432 1.2× 425 1.3× 290 5.4k
Hans Dieter Nischalke Germany 32 1.3k 0.6× 1.4k 0.8× 1.0k 2.2× 241 0.7× 322 1.0× 91 2.8k

Countries citing papers authored by Christopher Koh

Since Specialization
Citations

This map shows the geographic impact of Christopher Koh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher Koh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher Koh more than expected).

Fields of papers citing papers by Christopher Koh

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher Koh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher Koh. The network helps show where Christopher Koh may publish in the future.

Co-authorship network of co-authors of Christopher Koh

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher Koh. A scholar is included among the top collaborators of Christopher Koh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher Koh. Christopher Koh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Koh, Christopher, et al.. (2025). Portal sinusoidal vascular diseases: Assessment and therapy. Hepatology.
2.
Fuss, Ivan J., Jenna Bergerson, Jacqueline Laurin, et al.. (2024). Prospective evaluation of patients with non‐cirrhotic portal hypertension: A single centre study. Alimentary Pharmacology & Therapeutics. 59(12). 1527–1538. 2 indexed citations
3.
Uchida, Takuro, Masataka Tsuge, Nobuhiko Hiraga, et al.. (2024). Interferon alpha induces a stronger antiviral effect than interferon lambda in HBV/HDV infected humanized mice. Virus Research. 349. 199451–199451.
4.
Dahari, Harel, et al.. (2024). Advances and Challenges in Managing Hepatitis D Virus: Evolving Strategies. Current Hepatology Reports. 23(1). 32–44. 3 indexed citations
5.
Hercun, Julian, Anusha Vittal, Jenna Bergerson, et al.. (2024). Development of hepatic fibrosis in common variable immunodeficiency‐related porto‐sinusoidal vascular disorder. Alimentary Pharmacology & Therapeutics. 60(7). 888–896. 1 indexed citations
6.
Townsend, Elizabeth C., Lisa Scheuing, Shakuntala Rampertaap, et al.. (2024). Taurine-conjugated bile acids and their link to hepatic S1PR2 play a significant role in hepatitis C–related liver disease. Hepatology Communications. 8(7). 7 indexed citations
7.
Heller, Theo, et al.. (2023). Diagnosis of HDV: From virology to non‐invasive markers of fibrosis. Liver International. 43(S1). 31–46. 2 indexed citations
8.
Koh, Christopher, et al.. (2023). Noninvasive measures of portal hypertension. Clinical Liver Disease. 22(2). 58–61.
9.
Lee, Sungwon, Daniel C. Elton, Alexander H. Yang, et al.. (2022). Fully Automated and Explainable Liver Segmental Volume Ratio and Spleen Segmentation at CT for Diagnosing Cirrhosis. Radiology Artificial Intelligence. 4(5). e210268–e210268. 23 indexed citations
10.
Yakov, Gil Ben, Devika Kapuria, David E. Kleiner, et al.. (2022). Tip of the iceberg: A comprehensive review of liver disease in Inborn errors of immunity. Hepatology. 76(6). 1845–1861. 7 indexed citations
11.
Da, Ben L., Pallavi Surana, Varun Takyar, et al.. (2019). Vibration‐controlled transient elastography for the detection of cirrhosis in chronic hepatitis D infection. Journal of Viral Hepatitis. 27(4). 428–436. 27 indexed citations
12.
Da, Ben L., Pallavi Surana, Devika Kapuria, et al.. (2019). Portal Pressure in Noncirrhotic Portal Hypertension: To Measure or Not to Measure. Hepatology. 70(6). 2228–2230. 13 indexed citations
13.
Koh, Christopher, Ma Ai Thanda Han, Peter J. Walter, et al.. (2019). A randomized, proof-of-concept clinical trial on repurposing chlorcyclizine for the treatment of chronic hepatitis C. Antiviral Research. 163. 149–155. 7 indexed citations
14.
Yakov, Gil Ben, Hawwa Alao, Pallavi Surana, et al.. (2019). Vibration Controlled Transient Elastography (Fibroscan®) in sickle cell liver disease ‐ could we strike while the liver is hard?. British Journal of Haematology. 187(1). 117–123. 7 indexed citations
15.
Townsend, Elizabeth C., et al.. (2019). Exploring the Link Between Platelet Numbers and Vascular Homeostasis Across Early and Late Stages of Fibrosis in Hepatitis C. Digestive Diseases and Sciences. 65(2). 524–533. 6 indexed citations
16.
Da, Ben L., Theo Heller, & Christopher Koh. (2019). Hepatitis D infection: from initial discovery to current investigational therapies. Gastroenterology report. 7(4). 231–245. 31 indexed citations
17.
Da, Ben L., Pallavi Surana, Natasha Kamal, et al.. (2019). Twitter As a Noninvasive Bio‐Marker for Trends in Liver Disease. Hepatology Communications. 3(9). 1271–1280. 4 indexed citations
18.
Lo, Winifred, Bin Zhu, Arvind Sabesan, et al.. (2019). Associations of CDH1 germline variant location and cancer phenotype in families with hereditary diffuse gastric cancer (HDGC). Digital Commons@Becker (Washington University School of Medicine).
19.
Heller, Theo, Yaron Rotman, Christopher Koh, et al.. (2014). Long-term therapy of chronic delta hepatitis with peginterferon alfa. Alimentary Pharmacology & Therapeutics. 40(1). 93–104. 81 indexed citations
20.
Fan, Xiying, Bhaskar Upadhyaya, Liming Wu, et al.. (2012). CD40 agonist antibody mediated improvement of chronic Cryptosporidium infection in patients with X-linked hyper IgM syndrome. Clinical Immunology. 143(2). 152–161. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hiroshi Yatsuhashi Breakdown of academic impact, for papers by Zu‐Yau Lin Breakdown of academic impact, for papers by Georgios Germanidis Breakdown of academic impact, for papers by Akihiro Matsumoto Breakdown of academic impact, for papers by Norihiro Furusyo Breakdown of academic impact, for papers by Athanasios J. Archimandritis Breakdown of academic impact, for papers by Takeji Umemura Breakdown of academic impact, for papers by Norio Horiike Breakdown of academic impact, for papers by Jee‐Fu Huang Breakdown of academic impact, for papers by Hans Dieter Nischalke
Rankless by CCL
2026